| Description |
1 online resource (xii, 516 pages) : illustrations |
| Series |
Cancer drug discovery and development |
|
Cancer drug discovery and development.
|
| Contents |
Discovery of target molecules for cancer immunotherapy by genetic and bioinformatic approaches -- Current strategies for the identification of immunogenic epitopes of tumor antigens -- Current and future role of natural-killer cells in cancer immunotherapy -- The role of immune monitoring in evaluating cancer immunotherapy -- Statistical analysis of immune response assays -- DNA vaccines for cancer immunotherapy -- Dendritic cells -- Different approaches to dendritic cell-based cancer immunotherapy -- Anti-idiotype antibody vaccines for the immunotherapy of cancer -- Autologous tumor-derived heat shock protein vaccine as a new paradigm for individualized cancer therapeutics -- Tumor-reactive T-cells for adoptive immunotherapy -- T-cell adoptive immunotherapy of cancer: from translational models to clinical significance -- Retroviral-mediated gene transfer for engineering tumor-reactive T-cells -- Harnessing the potential of graft-vs-tumor -- Tumor-induced immune suppression and immune escape: mechanisms and impact on the outcome of immunotherapy of malignant disease -- The tumor microenvironment: regulation of antitumor immunity and implications for immunotherapy -- Manipulation of lymphocyte homeostasis for enhancing antitumor immunity -- Fast-lane evolution in the tumor microenvironment -- Manipulating immunological checkpoints to maximize antitumor immunity -- Interleukin-2 as cancer therapy -- Biological and clinical properties of the type 1 interferons -- Promising g [gamma]-chain cytokines for cancer immunotherapy: interleukins-7, -15, and -21 as vaccine adjuvants, growth factors -- The therapeutic use of natural-killer cells in hematological malignancies -- Antibody therapy for solid tumors -- Antibody therapy for non-Hodgkin's lymphoma -- Approaches to in vivo imaging of cancer immunotherapy -- Design issues for early-stage clinical trials for cancer vaccines -- Monoclonal antibody therapy for cancer |
| Summary |
Expert bench and clinical scientists join forces to concurrently review both the state-of-the-art in tumor immunology and its clinical translation into promising practical treatments. The authors explain in each chapter the scientific basis behind such therapeutic agents as monoclonal antibodies, cytokines, vaccines, and T-cells, and illustrate their clinical manipulation to combat cancer. Additional chapters address statistical analysis - both of clinical trials and assay evaluations - methods for the discovery of antigens, adoptive T cell therapy, and adaptive and innate immunity. The challe |
| Bibliography |
Includes bibliographical references and index |
| Notes |
Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002. http://purl.oclc.org/DLF/benchrepro0212 MiAaHDL |
|
Print version record |
|
digitized 2010 HathiTrust Digital Library committed to preserve pda MiAaHDL |
| Subject |
Cancer -- Immunotherapy.
|
|
Antineoplastic agents -- Design
|
|
Immunotherapy.
|
|
Neoplasms -- immunology
|
|
Neoplasms -- therapy
|
|
Antineoplastic Agents -- immunology
|
|
Vaccines -- immunology
|
|
Immunotherapy
|
|
MEDICAL -- Oncology.
|
|
HEALTH & FITNESS -- Diseases -- Cancer.
|
|
Antineoplastic agents -- Design.
|
|
Neoplasms -- immunology.
|
|
Antineoplastic Agents -- immunology.
|
|
Immunotherapy.
|
|
Vaccines -- immunology.
|
|
Cancer -- Immunotherapy.
|
|
Biomédecine.
|
|
Sciences de la vie.
|
|
Immunotherapy
|
|
Antineoplastic agents -- Design
|
|
Cancer -- Immunotherapy
|
|
Immuntherapie
|
|
Krebs Medizin
|
| Form |
Electronic book
|
| Author |
Disis, Mary L
|
| LC no. |
2005017065 |
| ISBN |
9781597450119 |
|
1597450111 |
|
1588295648 |
|
9781588295644 |
|
